Reversal of vasohibin-driven negative feedback loop of vascular endothelial growth factor/angiogenesis axis promises a novel antifibrotic therapeutic strategy for liver diseases

Authors

  • Suvro Chatterjee P.H.D.

    Corresponding author
    1. Vascular Biology Laboratory, AU-KBC Research Center, Chennai, India
    2. Center for Biotechnology, Anna University, Chennai, India
    • Address reprint requests to: Suvro Chatterjee, Ph.D., AU-KBC Research Center, MIT Campus of Anna University, Chromepet, Chennai 600044, India. E-mail: soovro@yahoo.ca; fax: +91 44 2223 1034.

    Search for more papers by this author

  • Potential conflict of interest: Nothing to report.

  • See Article on Page 633

  • This work was partially supported by a grant from the University Grant Commission Faculty Recharge Programme, Government of India (to S.C.).

No abstract is available for this article.

Ancillary